Additional warnings to be put in sales of 134 drugs

Published: 2013-02-07 06:57:00

Updated: 2013-02-07 06:57:00

The Korea Food and Drug Administration said on Tuesday that it instructed 79 pharmaceutical companies to add the warnings to the instructions of 134 medicinal products. Among the relevant products are Ofloxacin, lomefloxacin, gonadotropin-releasing hormone (GnRH) agonists and orlistat.

The in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK